The Market Reports

Synopsis

The global market for ESR Analyzers was estimated to be worth US$ 74.3 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on ESR Analyzers cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Erythrocyte Sedimentation Rate (ESR) can be defined as the rate at which red blood cells or erythrocytes sediment in a period of one hour. ESR is usually measured in millimeter per hour (mm/hr) and a value above 100 mm/hr indicates a disease condition, such as a disease that causes inflammation, active infection, cancer, heart disease, kidney disease, blood disease, diabetes, and collagen vascular disease.

Globally, the aging population (over 65 years) is rising significantly. Elderly patients often suffer from multiple chronic and inflammatory conditions requiring routine inflammation screening.

One of the primary drivers for ESR analyzers is the increasing global burden of chronic inflammatory diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), infections (e.g., tuberculosis, endocarditis), and other autoimmune conditions. ESR is a widely used biomarker for assessing inflammation and disease progression in these conditions.

Modern laboratories are adopting automated ESR analyzers to replace manual Westergren or micro-sedimentation methods, which are labor-intensive and time-consuming.

This report aims to provide a comprehensive presentation of the global market for ESR Analyzers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of ESR Analyzers by region & country, by Type, and by Application.

The ESR Analyzers market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ESR Analyzers.

Market Segmentation

By Company

• Alifax
• Streck
• ALCOR Scientific
• RR Mechatronics
• DIESSE Diagnostica
• JOKOH
• Sarstedt
• ELITechGroup
• Beijing Succeeder
• SFRI
• HemaTechnologies
• Disera

Segment by Type

• Big Sample Numbers
• Small Sample Numbers

Segment by Application

• Medical Use
• Scientific Research

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.